Global Buccal Drug Delivery Market, By Indication (Pain Management, Smoking Cessation, Angina Pectoris, Cough and Others), Type (Non-Attached Drug Delivery Systems and Bio-Adhesive Drug Delivery Systems), Design (Matrix Type and Reserviour Type), Dosage Forms (Solid Buccal Adhesive Dosage Forms, Semi-Solid Buccal Adhesive Dosage Forms, Liquid Buccal Adhesive Dosage Forms), Drugs (Oral Bioadhesive Formulation, Sublingual Formulation and Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
The buccal drug delivery market is expected to witness market growth at a rate of 7.20% in the forecast period of 2021 to 2028. Data Bridge Market Research report on buccal drug delivery market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the preference of macromolecules, including peptides, absorption enhancers and so forth is escalating the growth of aviation analytics market.
Buccal drug delivery can be described as a substitute technique for an oral drug delivered in which the drug is administrated through buccal mucosa of oral cavity. The drug is generally placed between the upper gums and cheeks to treat several disease and condition.
Major factors that are expected to boost the growth in the buccal drug delivery market in the forecast period are the rise in the need of buccal drug delivery for the ease of drug administration. Furthermore, the increase in the inclination towards the buccal drug delivery instead of conventional drug delivery method is further anticipated to propel the growth of the buccal drug delivery market. On the other hand, the rise in the prices involved in the research and development for novel formulation is further estimated to impede the growth of the buccal drug delivery market in the timeline period.
In addition, the implementation of the latest technologies in the health care industry will further provide potential opportunities for the growth of the buccal drug delivery market in the coming years. However, the scientific and major technical obstructions for the emerging of the drugs to be delivered via buccal might further challenge the growth of the buccal drug delivery market in the near future.
The buccal drug delivery market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the buccal drug delivery market scenario contact Data bridge market research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Buccal Drug Delivery Market Scope and Market Size
The buccal drug delivery market is segmented on the basis of indication, type,design, dosage forms, drugs and end users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of indication, the buccal drug delivery market is segmented into pain management, smoking cessation, angina pectoris, cough and others.
- On the basis of type, the buccal drug delivery market is segmented into non-attached drug delivery systems and bio-adhesive drug delivery systems.
- On the basis of design, the buccal drug delivery market is segmented into matrix type and reserviour type.
- On the basis of dosage forms, the buccal drug delivery market is segmented into solid buccal adhesive dosage forms, semi-solid buccal adhesive dosage forms, liquid buccal adhesive dosage forms. Solid buccal adhesive dosage forms is further sub segmented into buccal tablets, wafers, lozenges. Semi-solid buccal adhesive dosage forms is further sub segmented into gels, buccal patches, and buccal films.
- On the basis of drugs, the buccal drug delivery market is segmented into oral bioadhesive formulation, sublingual formulation and others. Oral bioadhesive formulation is further sub segmented into hydrocartisone succinate, hypromellose, miconazole, chlorohexidine. Sublingual formulation is further sub segmented into glycerin trinitrate and others.
- On the basis of end users, the buccal drug delivery market is segmented into hospitals, homecare, specialty clinics, and others.
Buccal Drug Delivery Market Country Level Analysis
The buccal drug delivery market is analysed and market size information is provided by country, indication, type, design, dosage forms, drugs and end users as referenced above.
The countries covered in the buccal drug delivery market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the buccal drug delivery market due to the rise in the developed pharmaceutical industry. Furthermore, the increase in the rate of diagnosis and treatment of diseases will further boost the growth of the buccal drug delivery market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the buccal drug delivery market due to the advancing of the pharmaceutical industry. Moreover, the occurrence of major domestic key players is further anticipated to propel the growth of the buccal drug delivery market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The buccal drug delivery market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Buccal Drug Delivery Market Share Analysis
The buccal drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to buccal drug delivery market.
The major players covered in the buccal drug delivery market report are Teva Pharmaceutical Industries Ltd, Pfizer Inc., Cynapsus, BioDelivery Sciences International, Inc, GlaxoSmithKline plc., MedLab, AstraZeneca, F. Hoffmann-La Roche Ltd, Dr. Reddy’s Laboratories Ltd, Sanofi, Generex Biotechnology Corp, Bayer AG, Takeda Pharmaceutical Company Limited., Novartis AG, Indivior PLC, Novo Nordisk A/S, NAPP PHARMACEUTICALS LIMITED, Endo Pharmaceuticals plc, Applied Pharma Research, ARDEA BIOSCIENCES LIMITED, among other domestic and global players. regenerative medicine market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Buccal Drug Delivery Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.